Financial Counselors Inc Amgen Inc Transaction History

Financial Counselors Inc

$6.18 Billion
Q2 2024

A detailed history of Financial Counselors Inc transactions in Amgen Inc stock. As of the latest transaction made, Financial Counselors Inc holds 77,090 shares of AMGN stock, worth $24.4 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

77,090

Previous 69,953 10.2%

Holding current value

$24.4 Million

Previous $19.9 Million 21.1%

% of portfolio

0.39%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $1.88 Million - $2.28 Million	7,137 Added 10.2%	77,090 $24.1 Million
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $392,281 - $473,533	-1,459 Reduced 2.04%	69,953 $19.9 Million
Q4 2023 Jan 26, 2024	SELL	$255.7 - $288.46 $585,297 - $660,284	-2,289 Reduced 3.11%	71,412 $20.6 Million
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $348,528 - $432,707	-1,594 Reduced 2.12%	73,701 $19.8 Million
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $156,202 - $184,706	729 Added 0.98%	75,295 $16.7 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $675,112 - $822,848	2,990 Added 4.18%	74,566 $18 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $25,422 - $32,302	-111 Reduced 0.15%	71,576 $18.8 Million
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $129,737 - $146,320	-578 Reduced 0.8%	71,687 $16.2 Million
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $8.15 Million - $9.07 Million	-35,334 Reduced 32.84%	72,265 $17.6 Million
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $958,429 - $1.06 Million	4,371 Added 4.23%	107,599 $26 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $514,502 - $588,801	-2,587 Reduced 2.44%	103,228 $23.2 Million
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $244,747 - $286,751	1,153 Added 1.1%	105,815 $22.5 Million
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $92,731 - $102,878	-397 Reduced 0.38%	104,662 $25.5 Million
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $2.64 Million - $3.08 Million	-11,916 Reduced 10.19%	105,059 $26.1 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $1.52 Million - $1.81 Million	-7,026 Reduced 5.67%	116,975 $26.9 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $180,211 - $200,409	768 Added 0.62%	124,001 $31.5 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $1.48 Million - $1.82 Million	7,486 Added 6.47%	123,233 $29.1 Million
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $2.29 Million - $3.04 Million	12,593 Added 12.21%	115,747 $23.5 Million
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $169,721 - $218,150	897 Added 0.88%	103,154 $24.9 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $616,871 - $739,140	3,543 Added 3.59%	102,257 $19.8 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $1.44 Million - $1.69 Million	8,637 Added 9.59%	98,714 $18.2 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $703,041 - $792,481	3,887 Added 4.51%	90,077 $17.1 Million
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $68,684 - $80,176	385 Added 0.45%	86,190 $16.8 Million
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $1.21 Million - $1.37 Million	-6,555 Reduced 7.1%	85,805 $17.8 Million
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $332,100 - $373,020	2,000 Added 2.21%	92,360 $17 Million
Q1 2018 Apr 26, 2018	BUY	$169.43 - $198.0 $1.25 Million - $1.47 Million	7,403 Added 8.92%	90,360 $15.4 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $3.16 Million - $3.53 Million	18,743 Added 29.19%	82,957 $14.4 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $318,520 - $363,664	1,904 Added 3.06%	64,214 $12 Million
Q2 2017 Aug 10, 2017	BUY	N/A	62,310	62,310 $10.7 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Amgen Inc Transaction History